Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kartikeya Bhardwaj

Showing results (1-10 of 2) with videos related to

Pageof 1
Sort By:
IEEE Transactions on Pattern Analysis and Machine Intelligence|April 30, 2024
Zero-Shot Neural Architecture Search: Challenges, Solutions, and OpportunitiesGuihong Li, Duc Hoang, Kartikeya Bhardwaj, et al.
Breast Cancer Research : BCR|August 13, 2020
Targetable ERBB2 mutation status is an independent marker of adverse prognosis in estrogen receptor positive, ERBB2 non-amplified primary lobular breast carcinoma: a retrospective in silico analysis of public datasetsSasagu Kurozumi, Mansour Alsaleem, Cíntia J Monteiro, et al.
Pageof 1

Showing results (1-10 of 2) with videos related to

Sort By:
Pageof 1
IEEE Transactions on Pattern Analysis and Machine Intelligence|April 30, 2024
Zero-Shot Neural Architecture Search: Challenges, Solutions, and OpportunitiesGuihong Li, Duc Hoang, Kartikeya Bhardwaj, et al.
Breast Cancer Research : BCR|August 13, 2020
Targetable ERBB2 mutation status is an independent marker of adverse prognosis in estrogen receptor positive, ERBB2 non-amplified primary lobular breast carcinoma: a retrospective in silico analysis of public datasetsSasagu Kurozumi, Mansour Alsaleem, Cíntia J Monteiro, et al.
Pageof 1